受取配当金、当期純利益、買収に伴うインプロセス研究開発費
- 【期間】
| 年度 | 受取配当金 | 当期純利益 | 買収に伴うインプロセス研究開発費 |
|---|
| 2008/03 | 8.59億 | | -170億 | | 880億 | |
| 2009/03 | 9.68億 | +12.7% | 477億 | 黒転 | - | |
| 2009/12 | 8.48億 | -12.4% | 539億 | +13.1% | - | |
| 2010/03 | 8.53億 | +0.6% | 403億 | -25.2% | 239億 | -72.9% |
| 2010/06 | 5.19億 | -39.2% | 188億 | -53.4% | - | |
| 2010/09 | 5.25億 | +1.2% | 399億 | +112.6% | - | |
| 2010/12 | 9.17億 | +74.7% | 674億 | +68.6% | - | |
| 2011/03 | 9.21億 | +0.4% | 674億 | +0% | - | |
| 2011/06 | 5.29億 | -42.6% | 135億 | -80% | - | |
| 2011/09 | 5.35億 | +1.1% | 333億 | +146.8% | - | |
| 2011/12 | 8.31億 | +55.3% | 492億 | +47.6% | - | |
| 2012/03 | 8.55億 | +2.9% | 585億 | +18.9% | - | |
| 2012/06 | 3.91億 | -54.3% | 119億 | -79.7% | - | |
| 2012/09 | 3.97億 | +1.5% | 245億 | +106.2% | - | |
| 2012/12 | 7.15億 | +80.1% | 340億 | +38.9% | - | |
| 2013/03 | 7.17億 | +0.3% | 483億 | +41.9% | - | |
| 2013/06 | 3.02億 | -57.9% | 94.1億 | -80.5% | - | |
| 2013/09 | 3.09億 | +2.3% | 277億 | +193.9% | - | |
| 2013/12 | 5.5億 | +78% | 295億 | +6.7% | - | |
| 2014/03 | 5.52億 | +0.4% | 330億 | +11.7% | - | |
| 2014/09 | - | | 105億 | -68.1% | - | |
| 2015/03 | 6.71億 | +21.6% | 211億 | +101% | - | |
| 2016/03 | 70.2億 | +946.5% | 672億 | +218.2% | - | |
| 2017/03 | 72億 | +2.6% | 204億 | -69.7% | - | |
| 2018/03 | 7.81億 | -89.2% | 334億 | +64.1% | - | |
| 2019/03 | 7.61億 | -2.6% | 468億 | +39.9% | - | |
| 2020/03 | 140億 | 大幅増 | 1181億 | +152.6% | - | |
| 2021/03 | 9.82億 | -93% | 72.3億 | -93.9% | - | |
| 2022/03 | 7.48億 | -23.8% | 67.4億 | -6.8% | - | |
| 2023/03 | 66.6億 | +789.8% | 305億 | +352.8% | - | |
| 2024/03 | 16.2億 | -75.7% | 203億 | -33.5% | - | |
